Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Nicorandil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-obstructive Coronary Artery Disease
1 trial -
Nicorandil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stable Angina
1 trial -
Nicorandil 5mg tid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Bypass Graft
1 trial -
Norepinephrine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Septic Shock
1 trial -
Normal saline
Xiyuan Hospital of China Academy of Chinese Medical Sciences
STEMI - ST Elevation Myocardial Infarction
1 trial -
Oxycodone Hydrochloride
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Analgesia, Patient-Controlled
1 trial -
PEG-rhG-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cervical Cancer
1 trial -
PEG-somatropin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Growth Hormone Deficiency
2 trials -
Placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastroesophageal Reflux Disease
1 trial -
Probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Kidney Disease
1 trial -
Propofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nausea and Vomiting
1 trial -
Propofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Urinary Surgery
1 trial -
Proton Pump Inhibitors
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Upper Gastrointestinal Hemorrhage
1 trial -
Qianjin Capsule of Gynaecology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pelvic Inflammatory Diseases
1 trial -
Qizhitongluo Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ischemic Stroke
1 trial -
Quick-Acting Heart Reliever
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Artery Stenosis
1 trial -
Rabbit ATG, (Genzyme)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aplastic Anemia
1 trial -
Recombinant human growth hormone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Achondroplasia
1 trial -
Recombinant human growth hormone (r-hGH)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dwarfism, Pituitary
1 trial -
Recombinant tissue plasminogen activator (rt-PA)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Thromboembolisms
1 trial -
Regimen:TDF+3TC+EFV
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hiv
1 trial -
RegimenοΌBIC+FTC+TAF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HIV Infection
1 trial -
Rematazolam Besylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Emergence Agitation
1 trial -
Reyanning mixture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Tonsillitis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources